| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
12,206 |
8,614 |
$895K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
549 |
421 |
$39K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,505 |
7,047 |
$25K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,106 |
3,067 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,946 |
1,476 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
125 |
116 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
153 |
104 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
92 |
57 |
$431.12 |
| 87428 |
|
120 |
91 |
$381.50 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$133.64 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,272 |
957 |
$48.14 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
101 |
73 |
$32.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
189 |
145 |
$22.48 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
14 |
14 |
$17.60 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
191 |
179 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
488 |
451 |
$0.00 |
| 1036F |
|
782 |
685 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,508 |
1,387 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
50 |
48 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
31 |
12 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
14 |
12 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,453 |
2,097 |
$0.00 |
| G9781 |
Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons) |
1,137 |
964 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18 |
13 |
$0.00 |